MORGAN STANLEY PLC/CALL/AMGEN/270/0.1/20.09.24 Share Price

Warrant

DE000MB0CPS8

Market Closed - Börse Stuttgart 19:20:09 05/07/2024 BST
4.19 EUR +3.71% Intraday chart for MORGAN STANLEY PLC/CALL/AMGEN/270/0.1/20.09.24
Current month-5.42%
1 month+0.72%
Date Price Change
05/07/24 4.19 +3.71%
04/07/24 4.04 -1.46%
03/07/24 4.1 -5.96%
02/07/24 4.36 +0.93%
01/07/24 4.32 -2.48%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 07:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Morgan Stanley
WKN MB0CPS
ISINDE000MB0CPS8
Date issued 09/11/2022
Strike 270 $
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 6.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.08
Lowest since issue 0.64
Delta0.84x
Omega 5.694
Premium1.58x
Gearing6.79x
Moneyness 1.151
Difference Strike -40.88 $
Difference Strike %-15.14%
Spread 0.03
Spread %0.71%
Theoretical value 4.225
Implied Volatility 33.65 %
Total Loss Probability 19.48 %
Intrinsic value 3.771
Present value 0.4540
Break even 315.80 €
Theta-0.05x
Vega0.03x
Rho0.04x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9 USD
Average target price
316.4 USD
Spread / Average Target
+1.79%
Consensus